Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review

GlobalData, April 2012, Pages: 139


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review

Summary

Shionogi & Co., Ltd., (Shionogi) is principally engaged in the manufacture of pharmaceutical products, diagnostics, and other related products in the fields of circulation, metabolism, infection, immunity and cancer pain. It operates through one reportable business segment, namely, Pharmaceuticals and related businesses. The company's core pharmaceuticals product business consists of three categories, namely, Prescription Drugs, OTC Drugs and Diagnostics. The company currently has 18 pipeline products in undergoing clinical trials. The company holds 17 subsidiaries and two distribution centers, namely, Shionogi Distribution Center, Osaka and Shionogi Tokyo Distribution Center, Chiba. The company operates in Japan, North America and Europe. It is headquartered in Osaka, Japan.


The company's strategy is to maximize its top line and bottom line growth by developing its pipeline products and investing in new growth drivers. Inline with its strategy the company recently entered into a worldwide licensing agreement with OncoTherapy Science, Inc.

Shionogi & Co., Ltd. Key Recent Developments

Feb 22, 2012: Plaintiff Cellectis Surrenders Claim Against Shionogi
Jan 30, 2012: Shionogi Establishes Developmental Subsidiary In EU
Jan 30, 2012: Shionogi Reports Net Sales Of JPY198.7 Billion For Nine Months Ended December 31, 2011
Nov 28, 2011: Shionogi To Announce Corporate Reorganization
Oct 31, 2011: Shionogi Reports Net Sales Of JPY124 Billion In H1 Fiscal 2012

This comprehensive SWOT profile of Shionogi & Co., Ltd. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds